Danaher Corporation (DHR) : Boltwood Capital Management reduced its stake in Danaher Corporation by 1.69% during the most recent quarter end. The investment management company now holds a total of 22,099 shares of Danaher Corporation which is valued at $1,776,760 after selling 380 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Jul 5, 2016.Danaher Corporation makes up approximately 1.48% of Boltwood Capital Management’s portfolio.
Other Hedge Funds, Including , Pensionfund Dsm Netherlands sold out all of its stake in DHR during the most recent quarter. The investment firm sold 50,500 shares of DHR which is valued $4,060,200.Cullinan Associates Inc reduced its stake in DHR by selling 100 shares or 0.19% in the most recent quarter. The Hedge Fund company now holds 51,325 shares of DHR which is valued at $5,251,574. Danaher Corporation makes up approx 0.43% of Cullinan Associates Inc’s portfolio. Toth Financial Advisory Corp added DHR to its portfolio by purchasing 8,054 company shares during the most recent quarter which is valued at $824,085. Danaher Corporation makes up approx 0.25% of Toth Financial Advisory Corp’s portfolio.
Danaher Corporation closed down -0.78 points or -0.96% at $80.08 with 56,13,809 shares getting traded on Monday. Post opening the session at $81.08, the shares hit an intraday low of $80.01 and an intraday high of $81.14 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.